POLA ORBIS Research and Development Expenses 2017-2025 | PORBF
POLA ORBIS research and development expenses from 2017 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
|
POLA ORBIS Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2016 | |
|
POLA ORBIS Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-09-30 | |
| 2025-03-31 | |
| 2024-03-31 | |
| 2023-03-31 | |
| 2022-03-31 | |
| 2021-03-31 | |
| 2020-03-31 | |
| 2019-03-31 | |
| 2018-03-31 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Cosmetics and Toiletries | $1.925B | $1.139B |
| POLA Orbis Holdings Inc. develops, manufactures and sells cosmetics and related products primarily in Japan and internationally. It offers cosmetics; skincare products; health foods and fashion items. The company's brand portfolio includes Jurlique, H2O, POLA, ORBIS, ORLANE, THREE and Decencia. POLA Orbis Holdings Inc. is headquartered in Tokyo, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estee Lauder (EL) | United States | $39.153B | 55.51 |
| DSM Firmenich AG - (DSFIY) | $19.952B | 0.00 | |
| Shiseido (SSDOY) | Japan | $8.694B | 241.78 |
| E.l.f Beauty (ELF) | United States | $4.813B | 32.60 |
| Coty (COTY) | United States | $2.209B | 11.41 |
| Nu Skin Enterprises (NUS) | United States | $0.408B | 6.48 |
| Helen Of Troy (HELE) | Bermuda | $0.407B | 4.17 |
| European Wax Center (EWCZ) | United States | $0.310B | 7.42 |
| Pitanium (PTNM) | Hong Kong, SAR China | $0.208B | 0.00 |
| Empro Group (EMPG) | $0.141B | 0.00 | |
| Solesence (SLSN) | United States | $0.094B | 133.00 |
| Natura &Co Holding S.A ADR (NTCOY) | Brazil | $0.000B | 0.00 |
| Waldencast (WALD) | United Kingdom | $0.000B | 0.00 |